4//SEC Filing
FASOLA KENNETH J 4
Accession 0001071739-24-000028
CIK 0001071739other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 7:38 PM ET
Size
8.3 KB
Accession
0001071739-24-000028
Insider Transaction Report
Form 4
CENTENE CORPCNC
FASOLA KENNETH J
EVP, Health Care Enterprises
Transactions
- Sale
Common Stock
2024-02-07$74.83/sh−8,190$612,858→ 239,175 total - Sale
Common Stock
2024-02-07$75.58/sh−3,810$287,960→ 235,365 total
Holdings
- 3,605.628
Phantom Stock
Exercise: $0.00From: 2023-03-10Exp: 2023-03-10→ Common Stock (3,605.628 underlying)
Footnotes (5)
- [F1]The weighted average price for this transaction is reported within the form. Shares were sold at prices ranging from $74.43 to $75.39. Full information regarding the number of shares at each price is available upon request.
- [F2]The weighted average price for this transaction is reported within the form. Shares were sold at prices ranging from $75.44 to $75.81. Full information regarding the number of shares at each price is available upon request.
- [F3]Ownership includes 180,027 shares of restricted stock subject to vesting requirements.
- [F4]Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock.
- [F5]The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Fasola's termination with the Company, or on such other date Mr. Fasola may elect.
Documents
Issuer
CENTENE CORP
CIK 0001071739
Entity typeother
Related Parties
1- filerCIK 0001030150
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 7:38 PM ET
- Size
- 8.3 KB